Class information for:
Level 1: ASAN FDN//DA 125//MED DIAGNOST PATHOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
14872 675 29.4 57%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1987 5071 JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ASAN FDN Address 33 83% 3% 19
2 DA 125 Author keyword 23 86% 2% 12
3 MED DIAGNOST PATHOL Address 21 90% 1% 9
4 ASAN FDNASAN MED Address 18 89% 1% 8
5 DA 8159 Author keyword 16 61% 3% 17
6 AZOSEMIDE Author keyword 15 68% 2% 13
7 U ARF Author keyword 14 100% 1% 7
8 DA 7867 Author keyword 11 78% 1% 7
9 DA 1131 Author keyword 6 80% 1% 4
10 BLOOD PARTITION Author keyword 6 100% 1% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DA 125 23 86% 2% 12 Search DA+125 Search DA+125
2 DA 8159 16 61% 3% 17 Search DA+8159 Search DA+8159
3 AZOSEMIDE 15 68% 2% 13 Search AZOSEMIDE Search AZOSEMIDE
4 U ARF 14 100% 1% 7 Search U+ARF Search U+ARF
5 DA 7867 11 78% 1% 7 Search DA+7867 Search DA+7867
6 DA 1131 6 80% 1% 4 Search DA+1131 Search DA+1131
7 BLOOD PARTITION 6 100% 1% 4 Search BLOOD+PARTITION Search BLOOD+PARTITION
8 DA 8164 6 100% 1% 4 Search DA+8164 Search DA+8164
9 FACTORS INFLUENCING PROTEIN BINDING 6 100% 1% 4 Search FACTORS+INFLUENCING+PROTEIN+BINDING Search FACTORS+INFLUENCING+PROTEIN+BINDING
10 1 3 DMU 4 75% 0% 3 Search 1+3+DMU Search 1+3+DMU

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DOSAGE REGIMENS 71 46% 17% 116
2 PHOSPHODIESTERASE V INHIBITOR 29 88% 2% 14
3 3 METHYLCHOLANTHRENE PRETREATMENT 27 83% 2% 15
4 AZOSEMIDE 23 79% 2% 15
5 EQUILIBRIUM DIALYSIS TECHNIQUE 17 100% 1% 8
6 INTRAVENOUS CHLORZOXAZONE 15 88% 1% 7
7 FT ADM 14 100% 1% 7
8 GI SEGMENTS 11 78% 1% 7
9 DRUG ELIMINATION 8 44% 2% 14
10 DOSE DEPENDENT ELIMINATION 8 100% 1% 5

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus 2010 22 177 58%
Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin 2015 1 75 27%
CYTOCHROME-P450 CHANGES IN RATS WITH STREPTOZOCIN-INDUCED DIABETES 1994 35 51 33%
Hepatic cytochrome P450 regulation in disease states 2001 65 126 20%
Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: Faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1 2007 9 39 56%
Effects of water deprivation on drug pharmacokinetics: Correlation between drug metabolism and hepatic CYP isozymes 2008 2 106 63%
Effects of endotoxin derived from Escherichia coli lipopolysaccharide on the pharmacokinetics of drugs 2008 20 63 21%
Strategies for preclinical pharmacokinetic investigation in streptozotocin-induced diabetes mellitus (DMIS) and alloxan-induced diabetes mellitus (DMIA) rat models: case studies and perspectives 2015 0 49 59%
Pharmacokinetics of drugs in mutant Nagase analbuminemic rats and responses to select diuretics 2014 0 72 57%
THE EFFECTS OF DIABETES-MELLITUS ON PHARMACOKINETICS AND PHARMACODYNAMICS IN HUMANS 1991 98 46 20%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ASAN FDN 33 83% 2.8% 19
2 MED DIAGNOST PATHOL 21 90% 1.3% 9
3 ASAN FDNASAN MED 18 89% 1.2% 8
4 AGROPHARMA 2 27% 1.0% 7
5 DIAGNOST PATHOL MED 1 18% 1.0% 7
6 GASTROENTEROL METAB PROD 1 100% 0.3% 2
7 YUHAN 1 23% 0.7% 5
8 RD PHARMACEUT 1 14% 1.2% 8
9 TOBONG GU 1 33% 0.3% 2
10 ASAN FDN DIAGNOST PATHOL 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000216426 CYP ISOZYMES//MOL RECOGNIT TECHNOL DEV IDM//CIENCIAS BASICAS FARMACEUT
2 0.0000152402 CYP2E1//CHLORZOXAZONE//6 HYDROXYCHLORZOXAZONE
3 0.0000112579 OLTIPRAZ//1 2 DITHIOLE 3 THIONES//1 2 DITHIOLE 3 THIONE
4 0.0000107455 TORASEMIDE//TORSEMIDE//FUROSEMIDE
5 0.0000092883 SERUM MEDIATORS//LY2216684//NEPHROLOGY CLINICAL PRACTICE GUIDELINES
6 0.0000089187 IPRIFLAVONE//TAK 778//ULMUS WALLICHIANA
7 0.0000072040 CYP2C12//ONE DAY TREATMENT//S BIOCHEM
8 0.0000068497 BOF 4272//MULTIPLE INDICATOR DILUTION//HEPATIC ELIMINATION
9 0.0000067817 7 HYDROXYMETHOTREXATE//GLUCARPIDASE//HIGH DOSE METHOTREXATE
10 0.0000064723 ROLLINS 5119//ANTIPYRINE PHARMACOKINETICS//CYTOCHROME P4502B1 2